HomeRDY • NYSE
Dr Reddy's Laboratories Ltd
$14.67
0.36%
+0.053 Today
After Hours:
$14.67
(0.00%)0.00
Closed: Jul 25, 4:01:12 PM UTC-4 · USD · NYSE · Disclaimer
Financials
Income Statement
020B40B60B80B
Revenue
Net Income
Revenue
Net income
(INR)Jun 2025Y/Y change
Revenue
85.45B11.37%
Operating expense
31.15B9.57%
Net income
14.18B1.85%
Net profit margin
16.59-8.54%
Earnings per share
17.021.94%
EBITDA
21.43B-1.36%
Effective tax rate
25.99%
0200B400B
Total Assets
Total Liabilities
Total assets
Total liabilities
(INR)Jun 2025Y/Y change
Cash and short-term investments
Total assets
Total liabilities
Total equity
Shares outstanding
832.04M
Price to book
Return on assets
Return on capital
11.38%
-2B02B4B6B
Net Change in Cash
Net change in cash
(INR)Jun 2025Y/Y change
Net income
14.18B1.85%
Cash from operations
Cash from investing
Cash from financing
Net change in cash
Free cash flow
StockUS listed securityIN headquartered
Previous close
$14.62
Day range
$14.54 - $14.69
Year range
$12.26 - $16.89
Market cap
12.16B USD
Avg Volume
1.51M
P/E ratio
18.69
Dividend yield
0.64%
About
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Founded
1984
Employees
27,811
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Finance
Search
Clear search
Close search
Main menu
Google apps